In Vitro Diagnostics IVD Market is Determined to Cross US$ 77 Billion By 2022

New York, March 26, 2018:

In Vitro Diagnostics IVD Market 2018

The Global In Vitro Diagnostics IVD Market is expected to exceed more than US$ 77 billion by 2022 and will grow at a CAGR of more than 5% in the given forecast period.

The scope of the report includes a detailed study of global and regional markets for Global In Vitro Diagnostics IVD Market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Affymetrix, Inc., AlereInc, Biomerieux, Danaher Corporation., Roche Diagnostics, Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Abbott Laboratories, Bayer AG., Arkray, Inc., Sysmex Corporation, Johnson & Johnson Pvt. Ltd. And Siemens AG. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

You Can Find Full Report @: https://www.marketresearchengine.com/reportdetails/global-in-vitro-diagnostics-ivd-market

The Global In Vitro Diagnostics IVD Market has been segmented as below:

By Product Analysis

• Reagents
• Instruments
• Software & Services

By Technique Analysis

• Immunodiagnostics
o Enzyme-Linked Immunosorbent Assay (ELISA)
o Enzyme-Linked ImmunoSpot (ELISPOT)
o Rapid Tests
o Western blot
o Radioimmunoassay (RIA)
• Blood Testing
• Molecular Diagnostics
o Polymerize Chain Reaction (PCR)
o Hybridization
o Isothermal Nucleic Acid Technology (INAAT)
o Microarray
o DNA diagnostics
o Others
• Tissue Diagnostics
• Clinical Chemistry
o Basic metabolic panel
o Lipid profile
o Liver panel
o Electrolyte panel
o Thyroid function panel
o Speciality chemicals
• Other IVD Techniques

By Application Analysis

• Infectious Diseases
• Cancer
• Cardiac Diseases
• Immune System Disorders
• Nephrological Diseases
• Gastrointestinal Diseases
• Other Indications

By End User Analysis

• Standalone Laboratory
• Hospitals
• Academic & Medical Schools
• Point of Care
• Others

By Regional Analysis

• North America
• Europe
• Asia-Pacific
• Rest of the World

This report provides:

1) An overview of the global market for In Vitro Diagnostics IVD and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for In Vitro Diagnostics IVD.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

The major driving factors of Global In Vitro Diagnostics IVD Market are as follows:

• Increasing demand for technically advanced diagnostic devices
• Technical expansion to develop high sensitivity point of care hematology testing
• Improved disposable income of customers gives high expansion potential for IVD market

The restraining factors of Global In Vitro Diagnostics IVD Market are as follows:

• Strict government rules
• Inauspicious reimbursement policies

Ask Sample Report: https://www.marketresearchengine.com/reportdetails/global-in-vitro-diagnostics-ivd-market

Table of Contents
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Trends
7 Global In Vitro Diagnostics Market, By Product & Service
8 Global In Vitro Diagnostics Market, By Technology
8.1 Introduction
8.2 Immunochemistry/Immunoassays
8.2.1 Enzyme-Linked Immunosorbent Assay (ELISA)
8.2.1.1 Chemiluminescence Immunoassays (CLIAS)
8.2.1.2 Fluorescence Immunoassays (FIAS)
8.2.1.3 Colorimetric Immunoassays (CIS)
8.2.2 Radioimmunoassay (RIA)
8.2.3 Rapid Tests
8.2.4 Western Blot
8.2.5 Enzyme-Linked Immunospot (Elispot) Assay
8.3 Clinical Chemistry
8.3.1 Basic Metabolic Panel
8.3.2 Electrolyte Panel
8.3.3 Liver Panel
8.3.4 Lipid Profile
8.3.5 Renal Profile
8.3.6 Thyroid Function Panel
8.3.7 Specialty Chemical Tests
8.4 Molecular Diagnostics (MDX)
8.4.1 Polymerase Chain Reaction (PCR)
8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.4.3 Microarray
8.4.4 Hybridization
8.4.5 Dna Sequencing & Next-Generation Sequencing
8.4.6 Other MDX Technologies
8.5 Clinical Microbiology
8.6 Hematology
8.7 Coagulation and Hemostasis
8.8 Other IVD Technologies
9 Global In Vitro Diagnostics Market, By Application
10 Global In Vitro Diagnostics Market, By End User
11 Global In Vitro Diagnostics Market, By Region
12 Competitive Landscape
13 Company Profiles
13.1 Introduction
13.2 ABBott Laboratories, Inc.
13.3 Becton, Dickinson and Company
13.4 Biomérieux SA
13.5 Bio-Rad Laboratories, Inc.
13.6 Danaher Corporation
13.7 Johnson & Johnson
13.8 Roche Diagnostics
13.9 Siemens AG
13.10 Sysmex Corporation
13.11 Thermo Fisher Scientific, Inc.
13.12 Ortho-Clinical Diagnostics, Inc.
13.13 Qiagen N.V.
13.14 Diasorin S.P.A.

About Us

Market Research Engine (MRE) is a next-generation provider of syndicated research, customized research, and consulting services. MRE’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each Market Research Engine’s research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.